THRESHOLD PHARMACEUTICALS INC·4

Feb 17, 6:46 PM ET

Pearce Tillman 4

4 · THRESHOLD PHARMACEUTICALS INC · Filed Feb 17, 2012

Insider Transaction Report

Form 4
Period: 2012-02-16
Pearce Tillman
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-02-16250,000250,000 total
    Exercise: $3.46Exp: 2022-02-16Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the Option shall vest and become exercisable on February 16, 2013. Thereafter the remaining shares will vest and become exercisable at a rate of 1/36th per month.

Documents

1 file
  • 4
    rrd334782.xmlPrimary

    PEARCE FORM 4